Logo

THTX

Theratechnologies Inc.

THTX

Theratechnologies Inc. NASDAQ
$3.39 0.00% (+0.00)

Market Cap $155.87 M
52w High $3.40
52w Low $1.12
Dividend Yield 0%
P/E -17.842105263157894
Volume 3.27M
Outstanding Shares 45.98M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q2-2025 $17.729M $14.934M $-4.462M -25.168% $-0.09 $-2.636M
Q1-2025 $19.047M $13.669M $117K 0.614% $0.002 $2.04M
Q4-2024 $25.002M $17.987M $-7.903M -31.609% $-0.15 $-3.974M
Q3-2024 $22.6M $11.866M $3.091M 13.677% $0.06 $6.618M
Q2-2024 $22.017M $14.182M $987K 4.483% $0.02 $4.467M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q2-2025 $9.921M $51.269M $79.191M $-27.922M
Q1-2025 $4.34M $56.451M $80.918M $-24.467M
Q4-2024 $9.622M $53.34M $78.612M $-25.272M
Q3-2024 $38.859M $69.712M $89.389M $-19.677M
Q2-2024 $36.028M $70.214M $93.422M $-23.208M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q2-2025 $-4.462M $12.403M $-8K $-6.885M $5.554M $12.395M
Q1-2025 $117K $-9.744M $-6.902M $4.665M $-11.994M $-19.848M
Q4-2024 $-7.903M $-227K $166K $-18.705M $-18.791M $-227K
Q3-2024 $3.091M $4.604M $779K $-1.868M $3.524M $4.604M
Q2-2024 $987K $-290K $-137K $-639K $-1.074M $-1.79M